Skip to content

PHARMACIE MULLER: what changed

BE 0834.875.832NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€47,380
2024 · €34,767+€12,613
Equity
€273,549
2024 · €269,631+€3,918
Cash
€227,382
2024 · €173,362+€54,021
Balance sheet total
€430,209
2024 · €401,872+€28,337

Largest movements

2024 to 2025
Assets
  • Cash +€54,021

    up €54,021 (+31.2%), from €173,362 to €227,382

    mainly Net result for the year (+€47,380) and Other debts (+€29,920)

  • Tangible fixed assets -€17,679

    down €17,679 (-15.5%), from €114,078 to €96,399

    of which Furniture and vehicles: -€12,371

  • Receivables within one year -€13,557

    down €13,557 (-29.7%), from €45,702 to €32,145

    of which Trade receivables: -€7,829

Equity and liabilities
  • Other debts +€29,920

    up €29,920 (+173%), from €17,248 to €47,168

  • Debts after one year -€10,261

    down €10,261 (-28.7%), from €35,744 to €25,483

  • Trade debts +€4,308

    up €4,308 (+9.6%), from €44,970 to €49,278

Income statement
  • Gross operating margin +€21,999

    up €21,999 (+16.1%), from €136,884 to €158,883

  • Staff costs +€3,959

    up €3,959 (+5.6%), from €71,064 to €75,023

  • Depreciation +€3,161

    up €3,161 (+20.1%), from €15,742 to €18,903

  • Taxes +€2,264

    up €2,264 (+16.9%), from €13,386 to €15,650

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €34,767
Gross operating margin +€21,999
Staff costs -€3,959
Depreciation -€3,161
Other operating charges +€5
Financial income -€56
Financial charges +€49
Taxes -€2,264
Result 2025 €47,380
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€108,591
Investment -€1,224
Financing -€53,347
Cash 2024 €173,362
Net result for the year +€47,380
Depreciation +€18,903
Stocks and contracts -€3,745
Receivables within one year +€13,557
Deferred charges and accrued income -€1,808
Trade debts +€4,308
Tax, wage and social debts -€99
Other debts +€29,920
Accrued charges and deferred income +€174
Investment in fixed assets (net) -€1,224
Debts after one year -€10,261
Current portion of long-term debt +€376
Contributions, distributions and other -€43,462
Cash 2025 €227,382
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €401,872 €430,209 +€28,337 +7.1%
Fixed assets 21/28 €114,078 €96,399 -€17,679 -15.5%
Tangible fixed assets 22/27 €114,078 €96,399 -€17,679 -15.5%
Land and buildings 22 €49,184 €45,671 -€3,513 -7.1%
Plant, machinery and equipment 23 €13,688 €11,893 -€1,795 -13.1%
Furniture and vehicles 24 €51,205 €38,834 -€12,371 -24.2%
Current assets 29/58 €287,795 €333,810 +€46,016 +16.0%
Stocks and contracts in progress 3 €67,214 €70,959 +€3,745 +5.6%
Stocks 30/36 €67,214 €70,959 +€3,745 +5.6%
Amounts receivable within one year 40/41 €45,702 €32,145 -€13,557 -29.7%
Trade receivables 40 €37,611 €29,782 -€7,829 -20.8%
Other amounts receivable 41 €8,091 €2,362 -€5,728 -70.8%
Cash at bank and in hand 54/58 €173,362 €227,382 +€54,021 +31.2%
Deferred charges and accrued income 490/1 €1,517 €3,325 +€1,808 +119%
Total equity and liabilities 10/49 €401,872 €430,209 +€28,337 +7.1%
Equity 10/15 €269,631 €273,549 +€3,918 +1.5%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €210,166 €214,085 +€3,918 +1.9%
Distributable reserves 133 €210,166 €214,085 +€3,918 +1.9%
Profit (loss) carried forward 14 €40,864 €40,864 = 0.0%
Amounts payable 17/49 €132,242 €156,660 +€24,418 +18.5%
Amounts payable after more than one year 17 €35,744 €25,483 -€10,261 -28.7%
Financial debts 170/4 €35,744 €25,483 -€10,261 -28.7%
Amounts payable within one year 42/48 €96,498 €131,003 +€34,505 +35.8%
Current portion of amounts payable after more than one year 42 €9,885 €10,261 +€376 +3.8%
Trade debts 44 €44,970 €49,278 +€4,308 +9.6%
Suppliers 440/4 €44,970 €49,278 +€4,308 +9.6%
Taxes, remuneration and social security 45 €24,395 €24,296 -€99 -0.4%
Taxes 450/3 €15,531 €10,611 -€4,920 -31.7%
Remuneration and social security 454/9 €8,864 €13,686 +€4,821 +54.4%
Other amounts payable 47/48 €17,248 €47,168 +€29,920 +173%
Accrued charges and deferred income 492/3 - €174 +€174
Remuneration, social security and pensions 62 €71,064 €75,023 +€3,959 +5.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,742 €18,903 +€3,161 +20.1%
Other operating charges 640/8 €137 €132 -€5 -3.4%
Gross operating margin 9900 €136,884 €158,883 +€21,999 +16.1%
Operating profit (loss) 9901 €49,942 €64,825 +€14,884 +29.8%
Financial income 75/76B €56 €0 -€56 -100.0%
Recurring financial income 75 €56 €0 -€56 -100.0%
Financial charges 65/66B €1,845 €1,796 -€49 -2.7%
Recurring financial charges 65 €1,845 €1,796 -€49 -2.7%
Profit (loss) for the period before taxes 9903 €48,153 €63,030 +€14,877 +30.9%
Income taxes 67/77 €13,386 €15,650 +€2,264 +16.9%
Profit (loss) for the period 9904 €34,767 €47,380 +€12,613 +36.3%
Profit (loss) for the period to be appropriated 9905 €34,767 €47,380 +€12,613 +36.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€289,164 to €350,120

Midpoint €314,562 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €273,549
Capitalised earnings €304,779 to €426,690
Indication €289,164 to €350,120

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€273,549
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€273,549

Capitalised earnings

net result for the year (9904)
2025
€47,380
2024
€34,767
2023
€45,861
2022
€25,712
2021
€36,356
Average result
€42,669
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€304,779 / €355,575 / €426,690

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 12 November 2026 via checked.be.